These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6684873)

  • 21. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea.
    Tantisira B; Tantisira MH; Patarapanich C; Sooksawate T; Chunngam T
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and pharmacological properties of some N-aroylhomotryptamines.
    Misztal S; Boksa J; Chojnacka-Wójcik E; Tatarczyńska E
    Pol J Pharmacol Pharm; 1979; 31(2):149-56. PubMed ID: 315061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sedative, antiepileptic and antipsychotic effects of Spondias mombin L. (Anacardiaceae) in mice and rats.
    Ayoka AO; Akomolafe RO; Iwalewa EO; Akanmu MA; Ukponmwan OE
    J Ethnopharmacol; 2006 Jan; 103(2):166-75. PubMed ID: 16188408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal experiments on the safety pharmacology of lofexidine.
    Graf E; Sieck A; Wenzl H; Winkelmann J
    Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of the new anticonvulsant etazepine.
    Borsini F; Volterra G; Cutrufo C; Furio M; Meli A
    Arzneimittelforschung; 1989 Apr; 39(4):475-9. PubMed ID: 2787643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the nonspecific central nervous system effects of the novel antitussive compound vadocaine hydrochloride.
    Karttunen P; Männistö PT; Lahovaara S; Havas A
    Arzneimittelforschung; 1988 Apr; 38(4A):605-8. PubMed ID: 3395395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacologic properties of pyridoyl derivatives of 3-methylaminoindole 2-methyltryptamine and isotryptamine.
    Misztal S; Wiertek J; Rogóz Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(6):851-62. PubMed ID: 1015991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of alaphen on some functions of central nervous system].
    Masiuta GF
    Farmakol Toksikol; 1966; 29(5):524-7. PubMed ID: 5995061
    [No Abstract]   [Full Text] [Related]  

  • 29. Central action of new derivatives of tetrahydropirimidinedione-4,6.
    Wilimowski M; Witkowska M; Kedzierska L; Barczyńska J; Wojewódzki W; Felsztyńska J
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):397-405. PubMed ID: 475560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1-Pyridyl-3,4-dihydro-beta-carbolines: synthesis and central action.
    Misztal S; Boksa J; Chojnacka-Wójcik E; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1986; 38(5-6):555-65. PubMed ID: 3494988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticonvulsant efficacy/safety properties of 2-amino-N-(1,2-diphenylethyl)acetamide hydrochloride.
    Palmer GC; Stagnitto ML; Garske GE; Napier JJ; Harris EW; Kaiser FC; Griffith RC; Woodhead JH; White HS; Wolf HH
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1023-31. PubMed ID: 7791072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice.
    Librowski T; Czarnecki R; Mendyk A; Jastrzebska M
    Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part II.
    Jasztold-Howorko R; Machoń Z; Wilimowski M; Wojewódzki W; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Duś E; Rutkowska M; Szelag A
    Pol J Pharmacol Pharm; 1992; 44(4):393-406. PubMed ID: 1287603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central action of 2-amino- and 2-amino-5-aryltetrahydropyrimidinediones-4,6.
    Wilimowski M; Witkowska M; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Wojewódzki W; Felsztyńska J
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):569-79. PubMed ID: 1164157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of increased fibrinolytic activity of rats blood on the action of some centrally acting drugs.
    Lukaszyk A; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1982; 34(1-3):93-100. PubMed ID: 7167425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropharmacological actions of panchagavya formulation containing Emblica officinalis Gaerth and Glycyrrhiza glabra Linn in mice.
    Achliya GS; Wadodkar SG; Avinash KD
    Indian J Exp Biol; 2004 May; 42(5):499-503. PubMed ID: 15233476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central action of glucagon.
    Morawska D; Sieklucka-Dziuba M; Kleinrok Z
    Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Substances with central nervous system activity. Derivatives of octahydro-1,4-dihydroxypyrrolo(1,2-a)pyrazine-6-carboxylic acids].
    Occelli E; Mariani L; Fontanella L; Corsico N
    Farmaco Sci; 1984 Aug; 39(8):718-38. PubMed ID: 6541160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central action of Craviten (M-71).
    Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
    Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isolation and pharmacodynamic activity of the sesquiterpene valeranone from Nardostachys jatamansi DC].
    Rücker G; Tautges J; Sieck A; Wenzl H; Graf E
    Arzneimittelforschung; 1978; 28(1):7-13. PubMed ID: 580202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.